|
Comprehensive Analysis of R&D and Commercialization for Related Biotechnologies from Non-Biotechnology/Non-Pharmaceutical Companies 100Published by: Fuji-Keizai USA, Inc. Published: Feb. 22, 2007 - 200 Pages The price of this report has been reduced.Table of Contents
AbstractThis Fuji-Keizai USA report explores research and development activities, business operations, investments and overall policies on biotechnology from the non-pharmaceutical, non-biotech company perspective. The organizations included in this report were selected because their core business is outside pure-play biotechnology and pharmaceutical drug development. The purpose is to understand to what extent, and why, industries such as IT, chemical companies, electronics giants, energy companies, among others, have an interest in biotechnology.Target Companies We start with a big picture of 100 non-pharma, non-biotech organizations. The organizations are predominantly U.S. Fortune 500 and European Fortune Global 500 businesses, as well as top U.S. hospitals and educational institutions. Next, we look at a piece of that organization - the divisional picture - and describe the business unit or other internal group, often within R&D, that is advancing biotechnology, either through commercialization of a product, internal research and/or a strategy of partnerships or acquisition. Our sources were publicly available data and phone interviews. Because the organizations come from different industrial sectors, their uses for biotechnology range from medicine, to consumer products such as clothing and food, to biofuel production. One of more biotechnology-related projects at each of the companies is described. Biotechnology Defined Biotechnology is synonymous with genomics (the study of genes) and proteomics (the study of proteins), where molecular biology and information technology are the tools used by scientists to develop advanced drugs. Because our scope is beyond pharmaceutical biotech alone, we have broadened the definition of biotechnology for this report to mean any technology where biological substances (e.g., human cells, tissue, plants, microorganisms, enzymes, etc.) are converted into a marketable product, system or process for medical or/and industrial application. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||